The main objective is to assess the feasibility and effectiveness of using activity trackers to increase physical activity and improve the emotional state of people receiving an in-patient treatment for alcohol use disorder
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
90
Fitbit Versa 3 is a commercially available activity tracker
In-patient alcohol use disorder treatment, including group therapy, counseling, and occupational activities
Therapeutical community "La Santina"
Gijón, Principality of Asturias, Spain
Physical activity tracker adherence
Days (percentage) in which activity tracker was used (day-time and night-time use)
Time frame: Treatment duration (4 weeks)
Physical activity tracker perceived utility
Perceived utility with the physical activity tracker will be assessed using ad-hoc questions about the utility of the activity tracker to increase levels of physical activity, improve sleep quality, and reduce/abandon tobacco.
Time frame: End-of-treatment (4 weeks)
Physical activity levels
Physical activity (PA) is operationalized as steps per day, plants climbed per day, distance covered per day (kilometers), light physical activity (minutes per day), moderate physical activity (minutes per week), vigorous physical activity (minutes per week), and sedentary time (hours per day). These outcomes will be measured using an adapted version of the International Physical Activity Questionnaire (IPAQ) and Fitbit Versa 3®.
Time frame: In-treatment (4 weeks), from enrollment to end-of treatment (4 weeks)
Depression symptoms
Depression symptoms will be measured using the Patient Health Questionnaire-9 (PHQ-9). This questionnaire ranges from 0 to 14. A higher punctuation means higher depression symptom levels.
Time frame: From enrollment to the end-of-treatment (4 weeks)
Anxiety symptoms
Anxiety symptoms will be measured using Generalized Anxiety Disorder-7 (GAD-7). This questionnaire ranges from 0 to 21. Higher punctuation means higher anxiety levels symptoms.
Time frame: From enrollment to the end-of-treatment (4 weeks)
Difficulties in emotion regulation
Emotion dysregulation is measured using the Difficulties in Emotion Regulation Scale (DERS). Emotional dysregulation of negative emotions is measured with the Difficulties in Emotion Regulation Scale (DERS). This scale ranges from 28 to 140 points. A higher score means more difficulties in emotion regulation.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: From enrollment to the end-of-treatment (4 weeks)
Physical activity tracker acceptability
Acceptability of the activity tracker is measured using the Participant Experience Questionnaire (PEQ). This scale ranges from 10 to 50 points. A higher score means higher acceptability.
Time frame: End-of-treatment (4 weeks)
Sleep quality
Sleep quality will be measured using both the Pittsburg Sleep Quality Index (PSQI) and the Fitbit Versa 3. PSQI ranges from 0 to 21 points. A higher score means lower sleep quality. In addition, Fitbit Versa 3 provides a sleep quality punctuation ranging from 0 to 100. A higher punctuation means better sleep quality.
Time frame: In-treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)
Tobacco use
Self-reported cigarettes per day and carbon monoxide (CO) levels measured by a CO monitor reading.
Time frame: In treatment (4 weeks), from enrollment to the end-of-treatment (4 weeks)
Delay discounting (impulsive decision making)
Delay discounting will be measured using the 21-item Monetary-Choice task. Computerized Delay Discounting task of tobacco (delay of one day, one week, one month, and six months).
Time frame: From enrollment to the end-of-treatment (4 weeks)